Literature DB >> 20520979

Melatonin protects the liver and erythrocytes against oxidative stress in cirrhotic rats.

Darlan Pase da Rosa1, Silvia Bona, Douglas Simonetto, Claudio Zettler, Cláudio Augusto Marroni, Norma Possa Marroni.   

Abstract

CONTEXT: Cirrhosis is a progressive chronic hepatopathy which constitutes an irreversible stage of liver dysfunction.
OBJECTIVES: To evaluate the oxidative stress in the blood of cirrhotic rats treated with the antioxidant melatonin.
METHODS: Cirrhosis was induced through inhalation of carbon tetrachloride. Liver integrity was evaluated by measuring serum enzymes, oxidative damage measured by lipoperoxidation, and antioxidant enzyme activity in erythrocytes. Lipoperoxidation, total nitrates, collagen, and histology by picrosirius staining were evaluated in the livers of these animals (n = 15), which were divided in three groups: control, carbon tetrachloride, and carbon tetrachloride + melatonin. Melatonin (20 mg/kg) was administered intraperitoneal from week 10 of carbon tetrachloride inhalation. In order to shorten the cirrhosis induction time, phenobarbital (0.3 g/L) was added to the animals' drinking water.
RESULTS: A significant impairment in the liver integrity of melatonin-treated animals as compared to cirrhotic animals was observed. In rat erythrocytes and liver, lipoperoxidation was significantly increased in the cirrhotic rats as compared to controls, as measured through thiobarbituric acid reactive substances, and significantly decreased in melatonin-treated animals as compared to cirrhotic ones. In blood, a decrease in superoxide dismutase and glutathione peroxidase enzymes was detected in the cirrhotic group as compared to the control group, with increased superoxide dismutase activity when melatonin was administered. A reduction in the levels of total nitrates was detected in the hepatic tissue of the animals in the carbon tetrachloride group as compared to the control group and an increase of these levels in the carbon tetrachloride + melatonin group. As for hepatic collagen, we found a significant increase in the carbon tetrachloride group as compared to the controls and a regression of these values in the treated group. In histology, the rats in the carbon tetrachloride group showed fibrosis and formation of fibrotic nodules, characterizing liver cirrhosis; there was reduction of nodules and fibrosis in the melatonin treated group.
CONCLUSION: The data allow us to suggest that the observed oxidative stress is related to the damages caused by carbon tetrachloride and that the use of melatonin can minimize these damages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20520979     DOI: 10.1590/s0004-28032010000100013

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  11 in total

1.  Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway.

Authors:  Yu-Rong Wang; Ru-Tao Hong; Yuan-Yuan Xie; Jian-Ming Xu
Journal:  Curr Med Sci       Date:  2018-04-30

2.  Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

Authors:  Yuyan Han; Paolo Onori; Fanyin Meng; Sharon DeMorrow; Julie Venter; Heather Francis; Antonio Franchitto; Debolina Ray; Lindsey Kennedy; John Greene; Anastasia Renzi; Romina Mancinelli; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

Review 3.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 4.  Melatonin regulation of biliary functions.

Authors:  Shannon Glaser; Yuyan Han; Heather Francis; Gianfranco Alpini
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

5.  Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes.

Authors:  Maura Floreani; Sara De Martin; Daniela Gabbia; Massimo Barbierato; Alberto Nassi; Claudia Mescoli; Rocco Orlando; Sergio Bova; Paolo Angeli; Elisabetta Gola; Antonietta Sticca; Pietro Palatini
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.

Authors:  Sura Wanessa Santos Rocha; Maria Eduarda Rocha de França; Gabriel Barros Rodrigues; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; André Filipe Pastor; Anne Gabrielle Vasconcelos Oliveira; Wilma Helena Oliveira; Rayana Leal Almeida Luna; Christina Alves Peixoto
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

7.  Antioxidant and anti-inflammatory action of melatonin in an experimental model of secondary biliary cirrhosis induced by bile duct ligation.

Authors:  Josieli Raskopf Colares; Elizângela Gonçalves Schemitt; Renata Minuzzo Hartmann; Francielli Licks; Mariana do Couto Soares; Adriane Dal Bosco; Norma Possa Marroni
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

8.  Melatonin restores zinc levels, activates the Keap1/Nrf2 pathway, and modulates endoplasmic reticular stress and HSP in rats with chronic hepatotoxicity.

Authors:  Silvia Bona; Sabrina Alves Fernandes; Andrea C Janz Moreira; Graziella Rodrigues; Elizângela G Schemitt; Fabio Cangeri Di Naso; Cláudio A Marroni; Norma P Marroni
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-03-05

9.  Effect of antioxidant treatment on fibrogenesis in rats with carbon tetrachloride-induced cirrhosis.

Authors:  Silvia Bona; Lidiane Isabel Filippin; Fábio Cangeri Di Naso; Cintia de David; Bruna Valiatti; Maximiliano Isoppo Schaun; Ricardo Machado Xavier; Norma Possa Marroni
Journal:  ISRN Gastroenterol       Date:  2012-04-02

10.  Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride.

Authors:  Silvia Bona; Graziella Rodrigues; Andrea J Moreira; Fábio C Di Naso; Alexandre S Dias; Thêmis R Da Silveira; Claudio A Marroni; Norma P Marroni
Journal:  JGH Open       Date:  2018-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.